Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?

被引：0
|
作者：
Claire L. Jansson-Knodell
Courtney E. Harris
Edward V. Loftus
Randall C. Walker
Mark J. Enzler
Abinash Virk
机构：
[1] Indiana University,Division of Gastroenterology and Hepatology
[2] Mayo Clinic,Department of Internal Medicine
[3] Mayo Clinic,Division of Gastroenterology and Hepatology
[4] Mayo Clinic,Division of Infectious Diseases
来源：
Digestive Diseases and Sciences | 2021年 / 66卷
关键词：
Fungal infection; Infliximab; Adalimumab; Certolizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：190 / 198
页数：8
相关论文
共 50 条
  • [1] Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
    Jansson-Knodell, Claire L.
    Harris, Courtney E.
    Loftus, Edward V., Jr.
    Walker, Randall C.
    Enzler, Mark J.
    Virk, Abinash
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (01) : 190 - 198
  • [2] Dermatoses in patients with inflammatory bowel disease under tumor necrosis factor-alpha inhibitors treatment
    Magalhaes, Carolina Mundim Couto
    Bartholo, Marina Ribeiro
    Correa, Bernardo Henrique Mendes
    Ferrari, Maria de Lourdes Abreu
    Ferrari, Teresa Cristina Abreu
    MEDICINA CLINICA, 2025, 164 (04): : 173 - 177
  • [3] Tumor Necrosis Factor-alpha Gene Polymorphisms in Korean Children with Inflammatory Bowel Disease
    Cho, Min Sung
    Song, Seung Min
    Oh, Seak Hee
    Lee, Yeoun Joo
    Jang, Ju Young
    Kim, Kyung Mo
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2011, 14 (03) : 269 - 278
  • [4] Association of tumor necrosis factor-alpha and -beta gene polymorphisms in inflammatory bowel disease
    Al-Meghaiseeb, Ebtissam Saleh
    Al-Robayan, Abdulrahman A.
    Al-Otaibi, Mulfi Mubarak
    Arfin, Misbahul
    Al-Asmari, Abdulrahman K.
    JOURNAL OF INFLAMMATION RESEARCH, 2016, 9 : 133 - 140
  • [5] Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease
    Peyrin-Biroulet, Laurent
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (26): : 2561 - 2561
  • [6] Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease
    Nielsen, Ole Haagen
    Ainsworth, Mark Andrew
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08): : 754 - 762
  • [7] RISK OF INVASIVE FUNGAL INFECTIONS WITH TUMOR NECROSIS FACTOR-ALPHA INHIBITORS AND CORTICOSTEROIDS AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Gregory, Martin H.
    Spec, Andrej
    Stwalley, Dustin
    Gremida, Anas K.
    Mejia-Chew, Carlos
    Nickel, Katelin B.
    Ciorba, Matthew A.
    Rood, Richard P.
    Olsen, Margaret A.
    Deepak, Parakkal
    GASTROENTEROLOGY, 2022, 162 (07) : S7 - S8
  • [8] Risk of Myeloid Neoplasms in Inflammatory Bowel Disease Patients Is Linked to Exposure to Thiopurines and Not With Tumor Necrosis Factor-alpha Inhibitors
    Deepak, Parakkal
    Stobaugh, Derrick J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (10) : 1857 - 1858
  • [9] Maternal and foetal adverse events with tumour necrosis factor-alpha inhibitors in inflammatory bowel disease
    Deepak, P.
    Stobaugh, D. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (09) : 1035 - 1043
  • [10] Histoplasmosis in Inflammatory Bowel Disease Patients on Tumor Necrosis Factor-a Medications
    Jansson-Knodell, Claire
    Moors, Courtney
    Loftus, Edward V., Jr.
    Walker, Randall
    Enzler, Mark
    Virk, Abinash
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S378 - S378
12345